American Society of Hematology

Fig. 7.

$Fig. 7. Leukemic samples from patients P30 and P52 wereEcoRI digested, size fractionated on 1% agarose gel, and hybridized with the following probes: (A) control probe bcl-1; (B) probe p6E3.2, with densitometry results of 0.52 in patient sample P30 compared with the P52, which had no loss detected with any 13q14 probe, showing hemizygous loss for P30; and (C) probe P9.19, which recognizes a 19 EcoRI band present in cosmid C9a, with densitometry results of 0.02 for the P30 sample compared with the P52 sample, showing homozygous loss for P30.$

Leukemic samples from patients P30 and P52 wereEcoRI digested, size fractionated on 1% agarose gel, and hybridized with the following probes: (A) control probe bcl-1; (B) probe p6E3.2, with densitometry results of 0.52 in patient sample P30 compared with the P52, which had no loss detected with any 13q14 probe, showing hemizygous loss for P30; and (C) probe P9.19, which recognizes a 19 EcoRI band present in cosmid C9a, with densitometry results of 0.02 for the P30 sample compared with the P52 sample, showing homozygous loss for P30.

This Feature Is Available To Subscribers Only